TCP-10a Inhibitors
TCP-10a inhibitors encompass a diverse array of chemical compounds that indirectly influence the activity and expression of TCP-10a through various cellular and molecular pathways. For instance, Trichostatin A operates as a histone deacetylase inhibitor, modifying chromatin structure, which in turn can suppress the transcription of genes including those encoding TCP-10a. Similarly, LY294002 and Wortmannin function as inhibitors of phosphoinositide 3-kinases, leading to a reduction in PI3K/AKT pathway signaling, potentially resulting in diminished expression or activity of TCP-10a. On the other hand, U0126 and PD98059 exert their effects by inhibiting the MAPK/ERK and MEK1/2 pathways, respectively. The downstream consequence of inhibiting these kinases is a likely reduction in theactivation or stability of TCP-10a, assuming its involvement in these pathways. SB431542's role in targeting the TGF-β type I receptor ALK5 impedes SMAD signaling that could be essential for TCP-10a's function, while rapamycin's inhibition of mTOR might lower overall protein translation levels, including that of TCP-10a.
Further, SP600125 disrupts JNK-mediated gene regulation which could encompass genes related to TCP-10a function, whereas IWP-2's attenuation of Wnt production may lead to lesser activation of pathways where TCP-10a plays a role. MG132 impedes proteasomal degradation, potentially leading to the accumulation of proteins that negatively control TCP-10a activity, while GW9662, a PPARγ antagonist, may alter gene expression patterns that affect TCP-10a. Lastly, Cyclopamine's inhibition of the Hedgehog pathway via the SMO receptor can decrease pathway signaling that might be crucial for TCP-10a activity. Collectively, these inhibitors target diverse biochemical pathways that, by virtue of their interconnectedness with TCP-10a function, could feasibly reduce its activity within the cell, delineating the multifaceted regulation of TCP-10a.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that leads to an accumulation of hyperacetylated histone proteins, thereby altering chromatin structure and affecting gene expression. This can indirectly inhibit TCP-10a by preventing the transcription of the gene necessary for its expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which are involved in various signaling pathways including those that may regulate the expression and activity of TCP-10a. By inhibiting PI3K, LY294002 can decrease the signaling that leads to the functional activation of TCP-10a. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MAPK/ERK kinase, which is part of the MAPK/ERK signaling pathway. Inhibition of this pathway by U0126 might reduce the expression or the activity of TCP-10a if it is downstream of or regulated by the MAPK/ERK pathway. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the transforming growth factor beta (TGF-β) type I receptor ALK5, which can lead to decreased phosphorylation and signaling of SMAD proteins. Since TCP-10a might be regulated by TGF-β signaling, SB431542 could indirectly reduce its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can lead to decreased protein synthesis. By inhibiting mTOR signaling, rapamycin may reduce the translation of mRNA into proteins, including TCP-10a, thus indirectly inhibiting its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of MEK1/2, enzymes upstream of ERK in the MAPK pathway. By blocking MEK1/2, PD98059 could reduce ERK-mediated signaling processes that may be necessary for the activation or stability of TCP-10a. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that blocks the PI3K/AKT pathway, which is implicated in a variety of cellular processes including protein synthesis and turnover. Inhibition of this pathway could diminish the activity or expression of TCP-10a. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which can disrupt signaling pathways that regulate gene expression. By inhibiting JNK activity, SP600125 may indirectly decrease the expression or activity of TCP-10a. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2 is an inhibitor of Wnt production, leading to decreased Wnt signaling. If TCP-10a is involved in Wnt signaling pathways, IWP-2 could indirectly reduce TCP-10a's functional activity by diminishing Wnt pathway activation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that prevents protein degradation. By inhibiting the proteasome, MG132 could accumulate proteins that negatively regulate TCP-10a, thus indirectly reducing its functional activity. | ||||||